Boston Family Office LLC Abbott Laboratories Transaction History

Boston Family Office LLC

  • $1.48 Billion
  • Q3 2024

A detailed history of Boston Family Office LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Boston Family Office LLC holds 86,990 shares of ABT stock, worth $9.94 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
86,990
Previous 86,839 0.17%
Holding current value
$9.94 Million
Previous $9.02 Million 9.92%
% of portfolio
0.67%
Previous 0.65%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$100.07 - $118.13 $15,110 - $17,837
151 Added 0.17%
86,990 $9.92 Million
Q2 2024

Aug 12, 2024
SELL
$100.73 - $112.44 $79,073 - $88,265
-785 Reduced 0.9%
86,839 $9.02 Million
Q1 2024

May 13, 2024
SELL
$109.52 - $120.96 $214,111 - $236,476
-1,955 Reduced 2.18%
87,624 $9.96 Million
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $53,392 - $65,356
-592 Reduced 0.66%
89,579 $9.86 Million
Q3 2023

Nov 13, 2023
SELL
$95.53 - $114.62 $95,530 - $114,620
-1,000 Reduced 1.1%
90,171 $8.73 Million
Q2 2023

Aug 14, 2023
SELL
$100.78 - $112.29 $353,435 - $393,801
-3,507 Reduced 3.7%
91,171 $9.94 Million
Q1 2023

May 10, 2023
SELL
$96.86 - $114.01 $9,589 - $11,286
-99 Reduced 0.1%
94,678 $9.59 Million
Q4 2022

Feb 07, 2023
SELL
$95.06 - $111.52 $539,940 - $633,433
-5,680 Reduced 5.65%
94,777 $10.4 Million
Q3 2022

Nov 08, 2022
SELL
$96.76 - $112.03 $134,786 - $156,057
-1,393 Reduced 1.37%
100,457 $9.72 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $18,168 - $21,959
-178 Reduced 0.17%
101,850 $11.1 Million
Q1 2022

May 11, 2022
SELL
$114.02 - $139.04 $48,116 - $58,674
-422 Reduced 0.41%
102,028 $12.1 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $88,264 - $108,075
-764 Reduced 0.74%
102,450 $14.4 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $12,599 - $13,938
108 Added 0.1%
103,214 $12.2 Million
Q2 2021

Aug 12, 2021
SELL
$105.79 - $124.53 $21,475 - $25,279
-203 Reduced 0.2%
103,106 $12 Million
Q1 2021

May 07, 2021
SELL
$108.84 - $128.23 $22,856 - $26,928
-210 Reduced 0.2%
103,309 $12.4 Million
Q4 2020

Feb 16, 2021
SELL
$105.0 - $114.42 $37,695 - $41,076
-359 Reduced 0.35%
103,519 $11.3 Million
Q3 2020

Nov 10, 2020
SELL
$91.64 - $111.29 $10,080 - $12,241
-110 Reduced 0.11%
103,878 $11.3 Million
Q2 2020

Aug 06, 2020
SELL
$76.57 - $98.0 $21,899 - $28,028
-286 Reduced 0.27%
103,988 $9.51 Million
Q1 2020

May 11, 2020
SELL
$62.82 - $91.86 $13,631 - $19,933
-217 Reduced 0.21%
104,274 $8.23 Million
Q4 2019

Feb 05, 2020
SELL
$78.51 - $87.4 $24,652 - $27,443
-314 Reduced 0.3%
104,491 $9.08 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $11,457 - $12,423
-140 Reduced 0.13%
104,805 $8.77 Million
Q2 2019

Jul 30, 2019
SELL
$72.88 - $85.0 $78,856 - $91,970
-1,082 Reduced 1.02%
104,945 $8.83 Million
Q1 2019

May 09, 2019
SELL
$66.22 - $80.06 $67,014 - $81,020
-1,012 Reduced 0.95%
106,027 $8.48 Million
Q4 2018

Feb 12, 2019
SELL
$65.56 - $74.27 $283,415 - $321,069
-4,323 Reduced 3.88%
107,039 $7.74 Million
Q3 2018

Nov 01, 2018
BUY
$60.81 - $73.36 $336,218 - $405,607
5,529 Added 5.22%
111,362 $8.17 Million
Q2 2018

Jul 26, 2018
BUY
$57.57 - $63.54 $90,672 - $100,075
1,575 Added 1.51%
105,833 $6.46 Million
Q1 2018

Apr 30, 2018
SELL
$56.27 - $63.62 $235,602 - $266,376
-4,187 Reduced 3.86%
104,258 $6.25 Million
Q4 2017

Feb 06, 2018
SELL
$53.68 - $57.47 $121,263 - $129,824
-2,259 Reduced 2.04%
108,445 $6.19 Million
Q3 2017

Nov 13, 2017
BUY
$48.06 - $53.64 $5.32 Million - $5.94 Million
110,704
110,704 $5.91 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email